Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 18.779K / 8.633M |
Day Range | - - - |
52 Wk Range | 99.140 - 133.100 |
Market Cap | $335.575B |
P/E Ratio | 941.071 |
Dividend Yield | 2.340% |
Exchange | NYSE |
RSI | 76 |
Short Interest | 0.66% |
Days to Cover | 2.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Cantor Fitzgerald on Wednesday, March 27, 2024. The analyst firm set a price target for 135.00 expecting MRK to rise to within 12 months (a possible 1.89% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $132.5 last updated Today at March 28, 2024 at 8:44 AM EDT.
A quarterly cash dividend of $0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on April 5, 2024 to stockholders of record on March 14, 2024.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.